[1]
Armstrong, A., Agada, N., Xu, W. and Gallo, G. 2018. An Update on the Long-Term Safety Experience of Ixekizumab: Results from the Psoriasis Clinical Development Program with More than 3 Years of Follow-up from 12 Clinical Trials and More Than 15000 Patient-Years of Exposure to Ixekizumab. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S116. DOI:https://doi.org/10.25251/skin.2.supp.105.